Patents Examined by Aaron Kosar
  • Patent number: 8101408
    Abstract: The invention may be summarized as follows. The present invention provides insecticides comprised of naturally-occurring compounds, such as, for example, PA1b-related peptides and terpenoid saponins. The present invention also provides for identification and characterization of a synergistic insecticidal effect between peptides and saponins extracted from plants. Furthermore, simplified extraction procedures are provided that avoid the use of a chloroform defatting step or a column chromatography step.
    Type: Grant
    Filed: June 9, 2009
    Date of Patent: January 24, 2012
    Assignee: Her Majesty the Queen in right of Canada, as represented by the Minister of Agriculture and Agri-Food
    Inventors: Wesley G. Taylor, Paul G. Fields, Daniel H. Sutherland
  • Patent number: 8076121
    Abstract: The present invention is generally directed to processes that integrate CO2-producing conversions of hydrocarbonaceous assets with biofuels processes that utilize CO2 in photosynthesis. In some embodiments, such processes involve the absorption of CO2 in an absorption liquid. In some such embodiments, such absorption is carried out in an absorption tower. In some other such embodiments, there is a subsequent desorption of the CO2. Generally, at least some of the CO2 captured by the absorption liquid is used to grow microbes or diatom species.
    Type: Grant
    Filed: July 25, 2007
    Date of Patent: December 13, 2011
    Assignee: Chevron U.S.A. Inc.
    Inventor: Dennis J. O'Rear
  • Patent number: 8076122
    Abstract: The present invention is generally directed to processes that integrate CO2-producing conversions of hydrocarbonaceous assets with biofuels processes that utilize CO2 photosynthesis. In some embodiments such processes involve the absorption of CO2 in an absorption liquid. In some such embodiments such absorption is carried out in an absorption tower. In some other such embodiments, there is a subsequent desorption of the CO2. Generally, at least some of the CO2 captured by the absorption liquid is used to grow microbes or diatom species.
    Type: Grant
    Filed: July 25, 2007
    Date of Patent: December 13, 2011
    Assignee: Chevron U.S.A. Inc.
    Inventor: Dennis J. O'Rear
  • Patent number: 8043836
    Abstract: The present invention is to provide an industrially advantageous method for producing an amino acid derivative. Provided is a method for producing an amino acid derivative including contacting a microorganism and/or an enzyme with a hydroxyimino acid represented by the following general formula (I): wherein R1 represents an optionally substituted predetermined hydrocarbon group; R2 represents a C1 to C3 alkyl group or a hydrogen atom; and n is 0 or 1, to produce an amino acid derivative represented by the following general formula (III): wherein R1 and n have the same meanings as those of R1 and n in the general formula (I), wherein the microorganism and/or the enzyme is capable of catalyzing the reaction.
    Type: Grant
    Filed: September 29, 2005
    Date of Patent: October 25, 2011
    Assignee: Ajinomoto Co., Inc.
    Inventors: Masakazu Sugiyama, Kunihiko Watanabe, Tadashi Takemoto, Kenichi Mori
  • Patent number: 8039011
    Abstract: Provided is a temperature change composition including a neurosensory component; and a first phase change component having a first phase change temperature between about 15 degrees C. and about 40 degrees C. Also provided is a temperature change composition including an evaporative cooling component; and a first phase change component having a first phase change temperature. Also provided is a temperature change composition for cooling skin, the composition including a first phase change component having a first phase change temperature; and a second phase change component having a second phase change temperature different from the first phase change temperature.
    Type: Grant
    Filed: October 10, 2006
    Date of Patent: October 18, 2011
    Assignee: Kimberly-Clark Worldwide, Inc.
    Inventors: Lisa Ann Flugge-Berendes, Scott W. Wenzel, Corey T. Cunningham, Pierre R. Joseph, Benjamin J. Kruchoski, Thomas G. Shannon
  • Patent number: 8017733
    Abstract: The invention relates to novel polyalkylene glycol compounds and methods of using them. In particular, compounds comprising a novel polyethylene glycol conjugate are used alone, or in combination with antiviral agents to treat a viral infection, such as chronic hepatitis C.
    Type: Grant
    Filed: July 16, 2004
    Date of Patent: September 13, 2011
    Assignee: Biogen Idec MA Inc.
    Inventors: KoChung Lin, R. Blake Pepinsky, Ling Ling Chen, Donna M. Hess, Edward Y. Lin, Russell C. Petter, Darren P. Baker
  • Patent number: 7998710
    Abstract: In the invention, highly pure crystals of difructose dianhydride III (di-D-fructofuranose-1,2?:2,3?-dianhydride; hereinafter referred to as DFA III) are produced by adding 5% or less of powdered active carbon to a DFA III containing purified solution containing DFA III of 90% or more purity at a concentration of R-Bx 10-60, preferably 40-55, and after stirring, applying the mixture to solid-liquid separation (filtration with diatomaceous, filtration through a membrane filter, ultrafiltration, or continuous centrifugal separation) and concentrating the separated liquid part, followed by immediate crystallization. In the process of the invention, DFA III crystals can be produced efficiently and industrially, and the resulting crystals can be used for various purposes in pharmaceuticals or food and drink since they have no smell. This is characteristics of the invention different from the prior art products.
    Type: Grant
    Filed: March 2, 2004
    Date of Patent: August 16, 2011
    Assignee: Nippon Beet Sugar Mfg., Co., Ltd.
    Inventors: Hiroto Kikuchi, Hiroaki Sakurai, Norimitsu Takagi, Tsutomu Aritsuka, Yoshihiro Senba, Fusao Tomita, Kozo Asano
  • Patent number: 7972835
    Abstract: A blood-viscosity reducing agent contains a protein derived from Bacillus subtilis natto and including, sequentially from an amino group terminal, a first structural amino acid sequence having alanine, threonine, aspartic acid, glycine, valine, glutamic acid, tryptophan, asparagine, valine, aspartic acid, glutamine, isoleucine, aspartic acid, alanine, proline, lysine, alanine, tryptophan, alanine, leucine, glycine, tyrosine aspartic, acid, glycine, threonine, glycine, threonine, valine, valine, alanine, serine, isoleucine, aspartic acid, threonine, glycine, valine, glutamic acid, tryptophan, asparagine, histidine, proline, alanine, leucine, lysine, glutamic acid, lysine, tyrosine, arginine, glycine, tyrosine, asparagine, proline, glutamic acid, asparagine, proline, asparagine, glutamic acid, proline, glutamic acid, asparagine, glutamic acid, methionine, asparagine, tryptophan, tyrosine, aspartic acid, alanine, valine, alanine, glycine, glutamic acid, alanine, serine, proline, tyrosine, aspartic acid, aspartic
    Type: Grant
    Filed: February 11, 2009
    Date of Patent: July 5, 2011
    Assignees: Daiwa Pharmaceutical Co., Ltd.
    Inventors: Masahito Hitosugi, Hiroaki Maeda, Kazunobu Omura
  • Patent number: 7972821
    Abstract: A method for the production of functional proteins including hormones by renal cells in a three dimensional culturing process responsive to shear stress uses a rotating wall vessel. Natural mixture of renal cells expresses the enzyme 1-?-hydroxylase which can be used to generate the active form of vitamin D: 1,25-diOH vitamin D3. The fibroblast cultures and co-culture of renal cortical cells express the gene for erythropoietin and secrete erythropoietin into the culture supernatant. Other shear stress response genes are also modulated by shear stress, such as toxin receptors megalin and cubulin (gp280). Also provided is a method of treating an in-need individual with the functional proteins produced in a three dimensional co-culture process responsive to shear stress using a rotating wall vessel.
    Type: Grant
    Filed: July 16, 2008
    Date of Patent: July 5, 2011
    Assignee: The United States of America as represented by the Administrator of the National Aeronautics and Space Administration
    Inventors: Thomas John Goodwin, Timothy Grant Hammond, James Howard Kaysen
  • Patent number: 7374775
    Abstract: The invention relates to dura substitutes to be used as prostheses for dural defects in the field of neurosurgery and processes for producing the same. The present invention provides artificial dura mater materials comprising sheets of microbial-derived polysaccharide processed to have the necessary strength characteristics, conformability and physical properties.
    Type: Grant
    Filed: August 23, 2004
    Date of Patent: May 20, 2008
    Assignee: Synthes (USA)
    Inventors: Christopher James Damien, Heather Ann Beam, Gerry Ann Oster, Frederick S. Wright, Gonzalo Serafica